Nokes Rachael 4
4 · scPharmaceuticals Inc. · Filed Jan 22, 2024
Insider Transaction Report
Form 4
Nokes Rachael
CFO and Treasurer
Transactions
- Award
Stock Option (right to buy)
2024-01-18+62,755→ 62,755 totalExercise: $5.76Exp: 2034-01-18→ Common Stock (62,755 underlying) - Award
Common Stock
2024-01-18+41,840→ 62,406 total
Footnotes (2)
- [F1]Consists of a restricted stock unit ("RSU") award made pursuant to the scPharmaceuticals Inc. 2017 Stock Option and Incentive Plan. The RSUs vest as to 25% of the shares underlying the RSUs on each of the first four anniversaries of January 1, 2024, such that the RSUs will be fully vested on January 1, 2028.
- [F2]The option shares vest over a four-year period, at a rate of 25% on January 1, 2025, with the remaining option shares vesting in 36 equal monthly installments thereafter, such that the option shares will be fully vested on January 1, 2028.